The carnitine-acylcarnitine translocase deficiency (CACTD) is caused by defect of CACT which catalyzes acylcarnitines to transport across the inner mitochondrial membrane in exchange of a free carnitine molecule. Here, SLC25A20 is linked to hyperinsulinemic hypoglycemia, familial, 4.